Magnetic resonance imaging brain volumetric study as a promising structural imaging marker in patients with Parkinson’s disease
Identifying biomarkers for neurodegenerative diseases is a challenging mission because of the difficulty of direct accessibility to the brain. Currently, the use of Magnetic Resonance Imaging (MRI) in the diagnosis of Parkinson’s disease (PD) is only to exclude secondary Parkinsonism. Our study aimed to evaluate if mea...